1985
DOI: 10.1080/15287398509530769
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic model to describe the disposition of lead in the rat

Abstract: A pharmacokinetic model was developed to describe the disposition of lead in the rat. The model can be used to predict the effect of acute high-dose as well as low-dose exposure to lead. These results suggest that the model should be able to predict the effect of chronic low-dose exposures as well. Plasma, bone, liver, and bile profiles were generated from this model using previously published data. The results obtained supported the existing theory that lead demonstrates a dose-dependent pharmacokinetic profi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1997
1997
2006
2006

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…Long-term exposure to Pb leads to PKC activation in rat livers; however, Pb also inhibited the activity of PKCα in a human hepatoma cell line (Liu et al 1997; Tonner and Heiman 1997), and the inhibition was much more pronounced when Pb levels were high (Sun et al 1999). Because circulating Pb will quickly deposit in the liver (Bornemann and Colburn 1985), we speculated (Cheng and Liu 2005) that a transient accumulation of Pb in the liver will suppress the activation of PKC and p42/44 MAPK in hepatocytes. Pb or LPS alone at the doses we used did not alter the phosphorylation of p42/44 MAPK in HepG2 cells (data not shown).…”
Section: Discussionmentioning
confidence: 99%
“…Long-term exposure to Pb leads to PKC activation in rat livers; however, Pb also inhibited the activity of PKCα in a human hepatoma cell line (Liu et al 1997; Tonner and Heiman 1997), and the inhibition was much more pronounced when Pb levels were high (Sun et al 1999). Because circulating Pb will quickly deposit in the liver (Bornemann and Colburn 1985), we speculated (Cheng and Liu 2005) that a transient accumulation of Pb in the liver will suppress the activation of PKC and p42/44 MAPK in hepatocytes. Pb or LPS alone at the doses we used did not alter the phosphorylation of p42/44 MAPK in HepG2 cells (data not shown).…”
Section: Discussionmentioning
confidence: 99%
“…Although Pb causes anemia and hypertension, damage to the kidneys, the nervous, endocrine, and reproductive systems, and neurologic, neurobehavioral, and developmental effects in children, Pb does not directly damage the liver (9). Excess free Pb may be released from the liver to the blood after rats are treated with high doses of Pb (10). It has been postulated that chronic lead poisoning does not cause liver damage, but that a huge single dose of lead will cause hepatic damage (11).…”
Section: Introductionmentioning
confidence: 99%
“…Cadmium is responsible for disorders like anemia, aborted fetus, neonatal death, heart problem (Kjellstrom, 1985) renal tubular dysfunction, disturbances of the calcium homeostasis (Staessen et al, 1992). Lead interferes with the activity of enzymes and effects many organs and systems such as kidneys and central nervous system (Bornemann and Colburn, 1985). The present study was conducted to isolate, characterize the air borne bacteria of the polluted environments and to study the relation ship of pollutants and bacterial genetic characters.…”
Section: Introductionmentioning
confidence: 99%